期刊:Advances in computational intelligence and robotics book series日期:2025-03-07卷期号:: 113-140
标识
DOI:10.4018/979-8-3693-6270-9.ch004
摘要
The usual use of artificial intelligence (AI) in drug research and discovery is poised to usher in a revolutionary era for the pharmaceutical sector. This chapter examines the significance of artificial intelligence in pharmaceutical engineering, emphasising significant developments and approaches that are transforming the discipline. AI is also accelerating the time-to-time market and cutting costs in clinical trials by optimising patient selection, providing real-time monitoring, and designing adaptive studies. This chapter also explores the regulatory environment, ethical issues, and the potential applications of AI in the pharmaceutical industry. This chapter intends to educate and motivate researchers, business experts, and legislators to fully use AI's promise to transform pharmaceutical engineering by offering a thorough review of the technology's role in drug discovery and development.